STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
종목 코드 STAA
회사 이름STAAR Surgical Co
상장일Feb 24, 1992
CEOFarrell (Stephen C)
직원 수1157
유형Ordinary Share
회계 연도 종료Feb 24
주소1911 Walker Ave
도시MONROVIA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호91016
전화16263037902
웹사이트https://www.staar.com/
종목 코드 STAA
상장일Feb 24, 1992
CEOFarrell (Stephen C)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음